How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?
AMA J Ethics. 2020; 22(1):E43-49. doi:
10.1001/amajethics.2020.43.
Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.
Mortality rates for breast cancer are higher where treatments are unavailable and unaffordable. Though less effective, breast examination could be a good screening approach.
AMA J Ethics. 2020; 22(2):E93-101. doi:
10.1001/amajethics.2020.93.
Most cancer deaths happen in low- and middle-income countries. Up to half of cancers are preventable, but several issues challenge prioritization of prevention, so it remains neglected.
AMA J Ethics. 2020; 22(2):E73-75. doi:
10.1001/amajethics.2020.73.